These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease. Lange G, Maurer J, Mann W. Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003 [Abstract] [Full Text] [Related]
3. [27 years experiences with transtympanic aminoglycoside treatment of Menière's disease]. Lange G. Laryngorhinootologie; 1995 Dec; 74(12):720-3. PubMed ID: 8579669 [Abstract] [Full Text] [Related]
4. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function. Helling K, Schönfeld U, Clarke AH. Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448 [Abstract] [Full Text] [Related]
9. Intratympanic gentamicin therapy for intractable Ménière's disease. De Beer L, Stokroos R, Kingma H. Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229 [Abstract] [Full Text] [Related]
10. Menière's disease and gentamicin: preliminary results using the minimum effective dose and integrated therapy. Sala T. Acta Otorhinolaryngol Ital; 2003 Apr; 23(2):78-87. PubMed ID: 14526554 [Abstract] [Full Text] [Related]
11. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
12. Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. Carey J. Otolaryngol Clin North Am; 2004 Oct; 37(5):1075-90. PubMed ID: 15474112 [Abstract] [Full Text] [Related]
14. Hearing results following intratympanic gentamicin perfusion for Ménière's disease. Kyrodimos E, Aidonis I, Sismanis A. J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493 [Abstract] [Full Text] [Related]
15. Effects of a single intratympanic gentamicin injection on Meniere's disease. Chung WH, Chung KW, Kim JH, Cho YS, Hong SH. Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572 [Abstract] [Full Text] [Related]
16. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease. Hillman TA, Chen DA, Arriaga MA. Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193 [Abstract] [Full Text] [Related]
17. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity. Kaplan DM, Hehar SS, Bance ML, Rutka JA. Laryngoscope; 2002 Apr; 112(4):689-95. PubMed ID: 12150525 [Abstract] [Full Text] [Related]
18. [Intratympanic gentamicin treatment for intractable Menière's disease]. Gilony D, Wolf M, Kronenberg J. Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278 [Abstract] [Full Text] [Related]
19. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
20. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing]. Akkuzu B, Ozgirgin N, Ozlüoğlu LN. Kulak Burun Bogaz Ihtis Derg; 2006 May; 16(5):193-9. PubMed ID: 17124437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]